BLOOD CANCERS
Clinical trials for BLOOD CANCERS explained in plain language.
Never miss a new study
Get alerted when new BLOOD CANCERS trials appear
Sign up with your email to follow new studies for BLOOD CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Threat attack on hidden leukemia cells aims to stop relapse
Disease control Recruiting nowThis study is testing whether a new combination of three drugs can safely control hidden leukemia cells and prevent the cancer from coming back in adults with acute myeloid leukemia (AML). The goal is to see if adding a new drug called tagraxofusp to two standard drugs helps elim…
Matched conditions: BLOOD CANCERS
Phase: PHASE1, PHASE2 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
New tool aims to personalize cancer care for older adults
Knowledge-focused Recruiting nowThis study is testing a new tool called PRIME that helps older adults with blood cancers and their doctors discuss treatment priorities. It compares whether using this tool helps patients feel their final treatment decision better matches their personal values compared to standar…
Matched conditions: BLOOD CANCERS
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC